REFERENCES
1. Hong YH, Sung JJ. Auto-reactive B cells in MuSK myasthenia gravis. Neuroimmunol Neuroinflammation 2016;3:196-7.
2. Guptill JT, Yi JS, Sanders DB, Guidon AC, Juel VC, Massey JM, Howard JF Jr, Scuderi F, Bartoccioni E, Evoli A, Weinhold KJ. Characterization of B cells in muscle-specific kinase antibody myasthenia gravis. Neurol Neuroimmunol Neuroinflamm 2015;2:e77.
3. Wallace ZS, Mattoo H, Carruthers M, Mahajan VS, Della Torre E, Lee H, Kulikova M, Deshpande V, Pillai S, Stone JH. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis 2015;74:190-5.
4. Iwata S, Saito K, Hirata S, Tanaka Y. Phenotypic changes of lymphocyte in a patient with IgG4-related disease after corticosteroid therapy. Ann Rheum Dis 2012;71:2058-9.
5. Maecker HT, McCoy JP, Nussenblatt R. Standardizing immunophenotyping for the Human Immunology Project. Nat Rev Immunol 2012;12:191-200.
6. Koarada S, Tada Y. Roles of plasmablasts in IgG4-related disease and various immune-based diseases. World J Rheumatol 2016;6:16-22.
7. Raibagkar P, Ferry JA, Stone JH. Is MuSK myasthenia gravis linked to IgG4-related disease? J Neuroimmunol 2017;305:82-3.
8. Jun H, Jung CW. Immunoglobulin G4-related inflammatory abdominal aortic aneurysm associated with myasthenia gravis, with contained rupture. Vasc Endovascular Surg 2016;50:571-4.
9. Huijbers MG, Zhang W, Klooster R, Niks EH, Friese MB, Straasheijm KR, Thijssen PE, Vrolijk H, Plomp JJ, Vogels P, Losen M, Van der Maarel SM, Burden SJ, Verschuuren JJ. MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4. Proc Natl Acad Sci U S A 2013;110:20783-8.
10. Delgado-García G, Corona-Vázquez T. IgG4-related disease and IgG4-mediated neurological autoimmune disorders: one and the same? J Neuroimmunol 2017;310:129-30.
11. Huijbers MG, Querol LA, Niks EH, Plomp JJ, van der Maarel SM, Graus F, Dalmau J, Illa I, Verschuuren JJ. The expanding field of IgG4-mediated neurological autoimmune disorders. Eur J Neurol 2015;22:1151-61.
